Weight loss alone does not explain lower heart disease for those on semaglutide
September 24, 2026
September 24, 2026
SOPHIA ANTIPOLIS, France, Sept. 24 [Category: Medical] -- The European Society of Cardiology posted the following news release:
* * *
Weight loss alone does not explain lower heart disease for those on semaglutide
*
Key takeaways:
* The SELECT trial has already shown a 20% lower risk of heart disease for people with overweight or obesity treated with semaglutide.
* New analysis of the trial suggests this cannot be fu . . .
* * *
Weight loss alone does not explain lower heart disease for those on semaglutide
*
Key takeaways:
* The SELECT trial has already shown a 20% lower risk of heart disease for people with overweight or obesity treated with semaglutide.
* New analysis of the trial suggests this cannot be fu . . .
